FDA Warns Four Compounders for Lacking Valid, Individual Prescriptions

Drug Industry Daily
The FDA sent warning letters to four compounding pharmacies, reminding them of their obligations under federal law to compound drug products based on valid prescriptions, while one compounder told the agency it was exempt from the FDA’s GMP requirements.

To View This Article:


Subscribe To Drug Industry Daily